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Abstract We evaluated the effect of chewing on blood
GLP-1 concentration by having volunteers to chew sugar-
less gum. Our intention was to explore the neural
mechanisms regulating the secretion of glucagon-like
peptide-1(GLP-1). After fasting for 12 h, 12 healthy male,
non-obese volunteers (18\BMI\ 30), were asked to
chew sugarless gum at a frequency of 80 times every 2 min
for a total of 30 min. Blood samples were collected before
the start of chewing and 5, 10, 15, 20, 25, and 30 min after
the start of chewing. Satiety and hunger were evaluated on
a scale from 0 to 100 at each time point. Compared with the
control group, the test group’s satiety was increased at 15,
25, and 30 min (p = 0.043, p = 0.014 and p = 0.018,
respectively) after they began chewing sugarless gum 80
times every 2 min. The blood GLP-1 level of the test group
at 30 min was 49.6 ± 20.3 pmol/l, significantly higher
than that of the control group (38.9 ± 20.9 pmol/l;
p = 0.031). There was no significant difference in the test
group’s GLP-1 concentration at each time point. In the
control group, compared to baseline, the GLP-1 concen-
trations at 15, 25, and 30 min were significantly decreased
(p = 0.042, p = 0.0214 and p = 0.012, respectively). No
significant differences in the blood concentration of glu-
cose, insulin and GIP or hunger were observed between
groups. Our study suggests that fasting sugarless gum
chewing can increase satiety and reduce the decrease in
GLP-1 concentration.
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Introduction
GLP-1 is synthesized in and secreted from enteroendocrine
L cells that were found throughout the small and large
intestine [1]. The constant basal secretion of GLP-1 from
enteroendocrine cells is rapidly augmented by the ingestion
of luminal nutrients, including carbohydrates, fats, and
proteins [2]. GLP-1 is extremely susceptible to the catalytic
activity of the enzyme dipeptidyl peptidase IV (DDP-IV)
[3]. Only approximately 10–15 % of newly secreted GLP-1
enters the systemic circulation in its intact form [4]. This
insulinotropic activity has been applied to the treatment of
type 2 diabetic patients in the form of a new class of an-
tidiabetic agents comprised GLP-1 receptor agonists and
dipeptidylpeptidase 4 (DPP-4) inhibitors [5].
Mastication, which serves the physiological function of
mechanically breaking food down into small particles
suitable for the gastrointestinal absorption of nutrients,
influences postprandial plasma glucose concentrations.
Compared with typical eating habits, the deliberately
thorough mastication of a test meal was reported to be
effective in reducing postprandial plasma glucose concen-
trations in subjects with normal glucose tolerance, most
likely because of greater early-phase insulin secretion [6].
If mastication can effect postprandial plasma GLP-1 con-
centration is not known.
Gum chewing is a voluntary physiological gross motor
activity that uses numerous functional neuroanatomical
pathways. Gum chewing has been associated with many
physiological changes, including increased blood flow in
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the cerebral and orofacial region, which may account for its
association with increased alertness and improved memory
[7].
Suggestions that chewing gum may positively influence
energy balance and facilitate weight loss have not been
convincingly demonstrated. In previous short-term studies,
gum chewing has been shown to reduce appetite and food
intake [8].
Recently, many scientists have contributed to research
examining the effect of gum chewing on weight loss;
however, these researchers have reached different conclu-
sions. Hetherington and Regan [9] found that chewing gum
for at least 45 min significantly suppressed self-reported
hunger, appetite, and snack cravings and promoted satiety.
Thus, their study demonstrated the benefits of chewing
gum as an aid in appetite control. In 2013, Japanese
scholars studied a group of healthy volunteers found that
chewed 30 times per bite had GLP-1 concentration that
were significantly higher than those of the normal group.
One possibility is that chewing 30 times per bite increased
the volume of glucose absorption via thorough mastication
and the extensive breakdown of carbohydrates [10]. Mattes
and Considine [11] found that chewing gum had no effects
on appetite sensations or gut peptide concentrations [11].
We suggest that chewing gum can increase GLP-1 se-
cretion and improve satiety.
Methods
Subjects
We have received approval from Ethic Committee of
Peking Union Medical College Hospital for this study.
Participants were recruited via public announcements.
Twelve male volunteers provided voluntary consent.
Screening prior to the study was conducted to ensure that
they met study criteria, i.e., were in good health (not taking
medications, no chronic diseases, diabetes or allergies,
teeth in a good state of repair). The participants’ height in
bare feet was measured. Fasting-state body weight was
measured to the nearest 0.1 kg. Eligibility was based on the
following criteria: 18–50 years of age; body mass index
18 kg/m2\BMI\ 30 kg/m2; good health; not initiating
or terminating the use of medications reported to affect
appetite or body weight during the proposed study period.
Study protocols
After an overnight fast, the healthy volunteers came to the
Endocrinology Department at the Peking Union Medical
College Hospital at 8 a.m. Their weight, height, blood
pressure, and heart rate were measured, and they were
interviewed regarding their past history and health condi-
tion. In a within-subject randomized cross-over comparison
of hormone concentrations in plasma, 12 subjects were
given sugarless gum. On one occasion the gum was chewed
(test day), on the other they did not chew the gum (control
day).
On each test occasion, after an overnight fast, a catheter
was placed into the subject’s antecubital vein and kept
patent for half an hour. On the test day, the participants
chewed sugarless gum (approximately 1.4 g) for half an
hour. The chewing frequency was controlled at 80 times
every 2 min. Chewing continued for half an hour. A nurse
was responsible for keeping time using a stopwatch. Ve-
nous blood was drawn immediately before the volunteers
began chewing (0 min) and 5, 10, 15, 25, and 30 min after
chewing began. A 2-ml blood sample was drawn in BD TM
P800 (Franklin Lakes, NJ, USA) Blood Collection Tubes
which was loaded with DPPIV, lipase, and proteinase in-
hibitor, then spun in a refrigerated centrifuge, and aliquots
of plasma were frozen immediately at -80 C.
Three days later, on the other occasion the individuals
returned to the hospital after an overnight fast, and the
same tests were performed with the patients chewing
nothing, as a control measure.
Laboratory analysis
We outsourced the testing of blood GLP-1 and GIP con-
centration to the Beijing North Institute of Biological
Technology (Beijing, China). The active GLP-1 [GLP-1-
(7-36 amide) and GLP-1-(7-37)] concentration were ana-
lyzed using a commercially available RIA assay kit
(GLP1A-35HK; Millipore, 6 Research Park Drive, St.
Charles, Missouri 63304, USA), and plasma total GIP was
analyzed using a commercially available enzyme-linked
immunosorbent assay kit (EZRMGIP-55 K; Millipore,
Billerica, MA). The intra- and interassay variations for
active GLP-1 were 4.8 and 9.7 %, respectively. The intra-
and interassay variations for GIP were 5 and 9.6 %, re-
spectively. Glucose was measured using a Roche Accu-
Check Performa clinical analyzer. Insulin was measured
using an ADVIA Centaur XP immunoassay system clinical
analyzer, and the sensitivity of the assay was 0.2 U/ml. The
intra- and interassay variations for insulin were 5 and
9.8 %, respectively.
Appetite profile
Appetite ratings were recorded on a visual analog scale
(VAS) (100 mm) presented on a meter ruler [12]. The
scales were anchored with ‘‘not at all’’ at one end and
‘‘extremely’’ at the other end and were combined with
questions regarding feelings of hunger and fullness. The
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VAS was completed seven times throughout the test day
and the control day at 0, 5, 10, 15, 20, 25, and 30 min.
Statistical analysis
Data are presented as the means ± SDs. The test and
control results were compared using paired t tests. Sample
size was calculated with power and sample size program.
We are planning a study of a continuous response variable
from matched pairs of study subjects. Prior data indicate
that the difference in the response of matched pairs is
normally distributed with standard deviation 15 pmol/l. If
the true difference in the mean response of matched pairs is
15 pmol/l, we will need to study 10 pairs of subjects to be
able to reject the null hypothesis that this response differ-
ence is zero with probability (power) 80 %. The type I
error probability associated with this test of this null hy-
pothesis is 0.05.
All statistical analyses were performed by using SPSS
19.0 (SPSS Inc), with a = 0.05. Statistical significance was
set at p\ 0.05 with a two-tailed test.
Results
Table 1 shows the clinical characteristics of the healthy
volunteers.
Table 2 and Figs. 1, 2 show the comparisons of plasma
glucose, serum insulin, plasma active GLP-1, and GIP
concentrations between the chewing and non-chewing oc-
casions. In both occasions, plasma glucose, serum insulin,
and GIP concentrations were equivalent. Paired t-tests
showed no significant differences between the two occa-
sions. Similarly, plasma GLP-1 concentrations 30 min after
chewing were significantly increased compared with the
non-chewing group (*p\ 0.05; 49.6 ± 20.3 pmol/l for the
groups that chewed gum vs. 38.9 ± 20.9 pmol/l for the
groups that did not chew gum).
Figures 3 and 4 show the comparison of fullness and
hunger between the chewing and non-chewing groups. A
paired t test showed a significant difference in fullness at 5,
15, and 30 min. The chewing group showed a significant
increase in fullness compared with the non-chewing group
(*p\ 0.05; 51.7 ± 10.3, 53.8 ± 15.7, and 58.5 ± 16.7 for
the group that chewed gum at 5, 15, and 30 min, respec-
tively, vs. 44.2 ± 6.7, 42.5 ± 7.5, and 43.3 ± 8.9 for the
group that did not chew gum at 5, 15, and 30 min, re-
spectively). Hunger ratings did not differ between the
chewing and non-chewing groups.
Discussion
Taste stimuli have a clear stimulating effect on satiety;
therefore, gum chewing is considered an effective weight
control method because it has the potential to control ap-
petite and food intake.
Gum chewing can provide taste stimuli, and because
each piece of gum contains only 5–10 kcal of energy, gum
chewing results in a net 11 ± 3 kcal/h increase in energy
expenditure [13]. We observed the effect of chewing hard,
sugarless gum on the GLP-1, and GIP concentration of
healthy volunteers. Our results show that chewing gum 80
times every 2 min during a fasting state made the blood
GLP-1 level of the chewing occasion decreasing more
slowly than that of the non-chewing group, and at 30 min
of chewing, the difference was significant. Furthermore,
fullness was increased at 5, 15, and 30 min after chewing
compared with non-chewing controls. For volunteers’
blood glucose level and insulin concentration had no dif-
ferent after chewing, we can conclude that change of GLP-
10s concentration is not originated from blood glucose’s
change. At the same time, GIP’s concentration has no
different after chewing, so change of GLP-10s concentra-
tion is independent of GIP’s level. Our results are consis-
tent with those from the research of Kokkinos et al. [14].
So we speculate that nerve system can regulate GLP-10s
secretion. It has been known for more than 20 years that
GLP-1 can be synthesized in the mammalian brain [15].
Some studies demonstrated that PPG neurons are non-
adrenergic neurons with their cell bodies located exclu-
sively in the caudal nucleus of the solitary tract (NTS), the
caudal medullary reticular formation and the olfactory bulb
[16, 17]. These studies also demonstrated a widespread
projection pattern for these neurons, with the highest
density of terminals observed in the paraventricular nu-
cleus (PVN) and the dorsomedial hypothalamus (DMH)
[16, 18]. At present, the nature of the link between the
GLP-1 of the central nervous system and the postprandial
release of peripheral GLP-1 and whether intestinal GLP-1
can enter the brain to fully activate the GLP-1 receptor
remain controversial. Our research suggests that chewing
can stimulate central nervous system and effect GLP-10s
level without food impacting. If GLP-1 was secreted from
Table 1 Clinical characteristics of healthy volunteers
Healthy volunteer
Number (male) 12
Age (y) 32.7 ± 9.3
Body mass index (kg/m2) 24.5 ± 2.1
Fasting blood glucose (mmol/l) 5.38 ± 0.31
Systolic pressure (mmHg) 124 ± 8
Diastolic pressure (mmHg) 76 ± 9
Heart rate (beats/min) 78 ± 11
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central nervous system itself is not know. But according
past study, it has a possibility that the increased GLP-1
comes from central nervous system.
The literature relating chewing gum to energy intake is
limited and nuanced by methodological variations. Studies
have examined the influence of gum chewing on body
weight, but the results are not consistent. Different methods
of chewing gum may lead to different effects. No effects
have been observed when chewing was set at a fixed time
(2 h after a meal) or in response to hunger [19]. Mixed
findings have been reported from chewing gum immediately
prior to a meal [19, 20]. Chewing gum may not decrease food
intake in all people. In addition, chewing sweet gum can
increase hunger [21] because it stimulates saliva secretion;
thus, chewing gum can stimulate rather than inhibit eating
[22]. In 2012, scholars in the United States make 102 over-
weight or obese adult volunteers to chew gum 90 min per day
for 8 weeks, and the result shows that this did not facilitate
weight loss in these overweight and obese adults [23].
In Japan, the practice of thorough mastication (for ex-
ample, 30 chews per bite) has been shown to be an effec-
tive behavioral approach for curbing obesity [24] because
the mastication-induced activation of histamine neurons
suppresses physical food intake through the H1-receptor in
the hypothalamic paraventricular nucleus and the ventro-
medial hypothalamus, which are known as satiety centers
[25]. By chewing slowly, healthy women can reduce
calorie intake [26].
The present study shows that chewing gum induced
changes in GLP-1 concentration independently of changes
Table 2 Comparison of glucose, insulin, GLP-1, and GIP between the gum-chewing and non-chewing occasions of healthy volunteers
0 min 5 min 10 min 15 min 20 min 25 min 30 min
Glucose (mmol/l)
Chewing 5.4 ± 0.3 5.4 ± 0.6 5.5 ± 0.4 5.6 ± 0.5 5.5 ± 0.5 5.5 ± 0.5 5.6 ± 0.6
Non-chewing 5.3 ± 0.4 5.5 ± 0.5 5.5 ± 0.6 5.5 ± 0.4 5.3 ± 0.6 5.5 ± 0.4 5.5 ± 0.5
Insulin (uIU/ml)
Chewing 10.1 ± 5.2 9.8 ± 5.7 8.9 ± 5.7 10.4 ± 6.2 9.5 ± 6.0 9.6 ± 5.8 9.1 ± 5.0
Non-chewing 9.4 ± 3.7 8.6 ± 3.5 8.3 ± 4.0 8.8 ± 3.4 8.2 ± 4.6 8.2 ± 4.1 8.1 ± 4.7
GLP-1 (pmol/l)
Chewing 52.2 ± 14.5 48.9 ± 17.3 57.6 ± 16.1 48.6 ± 15.9 52.7 ± 15.7 46.9 ± 20.7 49.6 ± 20.3*
Non-chewing 53.3 ± 16.4 57.6 ± 20.3 57.6 ± 21.4 45.8 ± 18,9 49.2 ± 25.2 42.5 ± 23.0 38.9 ± 20.9*
GIP (pg/ml)
Chewing 31.0 ± 15.0 33.5 ± 19.3 31.1 ± 18.7 29.1 ± 19.2 32.6 ± 23.5 30.4 ± 17.5 30.3 ± 13.5
Non-chewing 26.9 ± 17.1 25.4 ± 10.8 25.7 ± 11.2 27.1 ± 11.1 26.5 ± 12.5 24.5 ± 11.7 26.2 ± 17.1
* p\ 0.05
GLP-1


















Fig. 1 This figure shows the GLP-1 concentration for the chewing
group and the control group (n = 12). Plasma GLP-1 concentrations
30 min after chewing were significantly increased in the gum-
chewing group compared with the non-chewing group (*p\ 0.05)
GIP














Fig. 2 This figure compares the GIP concentration of the chewing
group and the control group (n = 12). There was no difference
between the gum-chewing group and the non-chewing group
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in blood glucose levels. At the same time, the GIP level did
not change with the change in GLP-1, which suggests that
the chewing action itself may be stimulate the secretion of
GLP-1; the nervous system regulates GLP-1 secretion in-
dependently of changes in GIP, and the action of chewing
has no effect on the secretion of GIP.
The effect of gum chewing on satiety emerges earlier
than the changes in blood hormones. After chewing for 5,
15, and 30 min, the chewing group’s satiety was sig-
nificantly higher than that of the control group. The blood
GLP-1 level on experiment days was always higher than
that on control days, and it was significantly higher in the
experimental group than the control group after chewing
for 30 min. There was no significant difference in GLP-1
concentration in the test group at each time point, a result
that was consistent with the volunteers’ self-reports.
Hunger levels did not differ significantly between the two
groups; further research can measure the plasma ghrelin
concentrations to verify this finding. In this experiment, the
blood sample quantity was limited, and we did not measure
other gastrointestinal hormones. Research shows that
chewing sugarless gum can increase satiety; therefore, gum
chewing may be a useful way to lose weight.
Some scholars suggest that the effects of neuropeptide
GLP-1 (released by PPG neurons) are distinct from the
effects of incretin GLP-1 (released by enteroendocrine
cells) and that the PPG neurons constitute a central sig-
naling network that integrates peripheral and central signals
for both long- and short-term nutritional and digestive
status. GLP-1 neurons might produce an output signal to
feeding and autonomic circuits that optimizes digestion and
the assimilation of nutrients and regulates calorific intake
[27]. We speculate that the chewing action itself may sti-
mulate the central PPG neurons to promote the release of
GLP-1.
Conclusion
Among healthy men in a fasting state, chewing sugarless
gum can increase satiety with no effect on blood glucose
and can decrease the decline of GLP-1 concentration.
Chewing gum has no significant effect on blood insulin and
GIP concentration. The present study suggests that chew-
ing sugarless gum may be an economical and effective
method to help obesity patients control their energy intake
and decrease weight with no changes in calorie intake.
Although there are different opinions about this benefit of
gum chewing, our study showed positive results, and it is
worth conducting a large-scale clinical research study to
verify the effectiveness of this method.
Conflict of interest The authors declare that they have no conflict
of interest.
Ethical standards All procedures performed in studies involving
human participants were in accordance with the ethical standards of
the institutional and/or national research committee and with the 1964
Helsinki declaration and its later amendments or comparable ethical
standards.
Informed consent Informed consent was obtained from all indi-
vidual participants included in the study.
Funding National Natural Science Foundation of China
(81170736).
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use, dis-
tribution, and reproduction in any medium, provided the original
author(s) and the source are credited.
Fullness
















Fig. 3 This figure shows the fullness ratings of the chewing group
and the control group (n = 12). Fullness at 5, 15, and 30 min after the
start of the session was significantly increased in the gum-chewing
group compared with the non-chewing group (*p\ 0.05)
Hunger













Fig. 4 This figure shows the hunger ratings of the chewing group and
the control group (n = 12). There was no difference between the
gum-chewing group and the non-chewing group
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